Ewing sarcoma of the head and neck: The Mayo Clinic experience.
Michael D OlsonKathryn M Van AbelRebecca N WehrsJoaquin J GarciaEric J MoorePublished in: Head & neck (2018)
Combined multimodal treatment resulted in a 5-year OS and RFS of 87% and 75%, respectively. Aggressive surgical resection with adjuvant chemoradiotherapy should be considered. Although negative margin surgery is the goal, subtotal resection may be acceptable in the setting of adjuvant treatment.